Mahak Arora
Overview
Explore the profile of Mahak Arora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Canova N, Sipkova J, Arora M, Pavlikova Z, Kucera T, Seda O, et al.
Front Pharmacol
. 2025 Feb;
16:1476994.
PMID: 39968178
Background: The complexity of the galaninergic system is still not fully understood, especially under specific pre-existing comorbidities related to metabolic dysfunction. A plant-derived triterpenoid celastrol was demonstrated to exert a...
2.
Pozniak J, Rysanek P, Smrcka D, Kozlik P, Krizek T, Smardova J, et al.
Front Pharmacol
. 2024 Mar;
15:1331637.
PMID: 38444938
Ivacaftor is a modern drug used in the treatment of cystic fibrosis. It is highly lipophilic and exhibits a strong positive food effect. These characteristics can be potentially connected to...
3.
Arora M, Pavlikova Z, Kucera T, Kozlik P, Sopin T, Vacik T, et al.
Biomed Pharmacother
. 2023 Sep;
167:115447.
PMID: 37683589
Knowledge of the benefits of mTOR inhibition concerning adipogenesis and inflammation has recently encouraged the investigation of a new generation of mTOR inhibitors for non-alcoholic steatohepatitis (NASH). We investigated whether...
4.
Hlusicka J, Arora M, Bruha R, Zak A
Cas Lek Cesk
. 2022 Jun;
161(2):80-83.
PMID: 35728963
Statins are widely accepted hypolipidemics that work by inhibiting hydroxymethylglutaryl coenzyme A reductase and thereby inhibiting cholesterol synthesis. They significantly reduce cardiovascular risk. Their use could be associated with side...
5.
Njeka Wojnarova L, Kutinova Canova N, Arora M, Farghali H
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
. 2022 Apr;
167(1):50-60.
PMID: 35416184
Aim: Currently available medicines have little to offer in terms of supporting the regeneration of injured hepatic cells. Previous experimental studies have shown that resveratrol and metformin, less specific activators...
6.
Arora M, Kutinova Canova N, Farghali H
Eur J Pharmacol
. 2022 Feb;
921:174857.
PMID: 35219732
Currently, non-alcoholic fatty liver disease (NAFLD) progressing into chronic non-alcoholic steatohepatitis (NASH), liver cirrhosis, and eventually hepatocellular cancer has emerged as an epidemiological concern due to lack of proven treatment....